AWM
ADCT icon

Aviso Wealth Management’s ADC Therapeutics ADCT Stock Holding History

Aviso Wealth Management’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.8K Hold
10,343
– – 0.02% 140
2025
Q4 		$36.5K Hold
10,343
– – 0.02% 146
2025
Q3 		$41.4K Hold
10,343
– – 0.02% 140
2025
Q2 		$27.7K Hold
10,343
– – 0.01% 144
2025
Q1 		$14.6K Hold
10,343
– – 0.01% 136
2024
Q4 		$20.6K Hold
10,343
– – 0.01% 143
2024
Q3 		$32.6K Hold
10,343
– – 0.02% 145
2024
Q2 		$32.7K Sell
10,343
-125
-1% -$497 0.02% 151
2024
Q1 		$47K Buy
+10,468
New +$38.6K 0.03% 148

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aviso Wealth Management's ADCT Position: Q1 2026 in Review

Aviso Wealth Management held its ADC Therapeutics (ADCT) position steady in Q1 2026 at 10,343 shares worth $38.8K. The position accounts for 0.02% of the portfolio, ranked #140.

Aviso Wealth Management first reported a position in ADCT in Q1 2024 and has held it in 9 quarters since. The position peaked at $47K in Q1 2024. 118 funds tracked by Wall St. Rank hold ADCT as of Q1 2026.

  • Aviso Wealth Management held 10,343 shares of ADC Therapeutics worth $38.8K as of Q1 2026.
  • Aviso Wealth Management left its ADC Therapeutics share count unchanged in Q1 2026.
  • ADC Therapeutics made up 0.02% of Aviso Wealth Management's portfolio in Q1 2026, its #140 holding.
  • Aviso Wealth Management first reported a position in ADC Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Aviso Wealth Management's ADC Therapeutics position peaked at $47K in Q1 2024.
  • 118 funds tracked by Wall St. Rank held ADC Therapeutics as of Q1 2026.

Based on Aviso Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.